Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gerald Proehl Insider Profile
4 Followers
Gerald Proehl, Director at Qualigen Therapeutics, holds 1.67K shares in Tenax Therapeutics (Ticker: TENX), holds 3.18M shares in Dermata Therapeutics (Ticker: DRMA), holds 50.00K shares in Qualigen Therapeutics (Ticker: QLGN).
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-73.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Gerald Proehl holds in companies
Most Profitable Insider Trade
Stock:
Sophiris Bio
(SPHS)
(SPHS)
Rating:Informative Buy
Date:Sep 19, 2014 - Sep 19, 2015
Return:-64.30%
The most profitable trade made by Gerald Proehl
Gerald Proehl's Trading History
Qualigen Therapeutics
Jun 25, 2015
Director
Informative Buy
250.00K
$195.00K
Tenax Therapeutics
Aug 08, 2024
Director
Uninformative Buy
―
$9.35K
Dermata Therapeutics
Nov 26, 2021
Pres., CEO & COB, Director
Informative Buy
48.00K
$3.43M
Sophiris Bio
Sep 19, 2014
―
Informative Buy
31.50K
$120.00
Auspex Pharma
May 05, 2015
―
Uninformative Sell
―
―
Santarus
Jan 06, 2014
―
Uninformative Buy
1000.00K
―
Assertio Therapeutics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Gerald Proehl's performance on stock
You May Also Like
Gerald Proehl insider profile FAQ
What is the percentage of profitable transactions made by Gerald Proehl?
The percentage of profitable transactions made by Gerald Proehl is 0%.
What is the average return per transaction made by Gerald Proehl?
The average return per transaction made by Gerald Proehl is -73.50%.
What stocks does Gerald Proehl hold?
Gerald Proehl holds: QLGN, TENX, DRMA, SPHS, ASPX, SNTS, ASRT stocks.
What was Gerald Proehl’s latest transaction?
Gerald Proehl latest transaction was an Uninformative Buy of ―.
What was Gerald Proehl's most profitable transaction?
Gerald Proehl’s most profitable transaction was an Informative Buy of SPHS stock on September 19, 2014. The return on the trade was -64.30%.
What is Gerald Proehl's role in Qualigen Therapeutics?
Gerald Proehl's role in Qualigen Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.